These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 22334636
1. The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: clinical analysis of 279 cases. Wang M, Mou C, Jiang M, Han L, Fan S, Huan C, Qu X, Han T, Qu Y, Xu G. Eur J Endocrinol; 2012 May; 166(5):797-802. PubMed ID: 22334636 [Abstract] [Full Text] [Related]
2. The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients. Huan C, Cui G, Ren Z. Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):713-8. PubMed ID: 25796163 [Abstract] [Full Text] [Related]
3. Role of Ki-67 in acromegalic patients with hyperprolactinemia: retrospective analysis in 61 Chinese Patients. Huan C, Cui G, Lu C, Qu X, Han T. Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):719-23. PubMed ID: 25796164 [Abstract] [Full Text] [Related]
4. A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin. De Marinis L, Zuppi P, Valle D, Mancini A, Bianchi A, Lauriola L, Pasquini P, Anile C, Maira G, Giustina A. Horm Metab Res; 2002 Mar; 34(3):137-43. PubMed ID: 11972303 [Abstract] [Full Text] [Related]
5. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly. Kim EH, Oh MC, Lee EJ, Kim SH. Neurosurgery; 2012 May; 70(5):1106-13; discussion 1113. PubMed ID: 22067418 [Abstract] [Full Text] [Related]
6. Pituitary adenomas in acromegalic patients: an immunohistochemical and endocrinological study with special reference to prolactin-secreting adenoma. Kanie N, Kageyama N, Kuwayama A, Nakane T, Watanabe M, Kawaoi A. J Clin Endocrinol Metab; 1983 Dec; 57(6):1093-101. PubMed ID: 6415083 [Abstract] [Full Text] [Related]
7. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients. Gsponer J, De Tribolet N, Déruaz JP, Janzer R, Uské A, Mirimanoff RO, Reymond MJ, Rey F, Temler E, Gaillard RC, Gomez F. Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206 [Abstract] [Full Text] [Related]
8. Immunohistochemical detection of glycoprotein hormone alpha subunit in somatoprolactinic and pure somatotroph adenomas. Vantyghem MC, Cortet C, Bauters C, Gevaert MH, Dewailly D, Lefebvre J, Mazzucca M. J Endocrinol Invest; 1998 Jul; 21(7):434-40. PubMed ID: 9766257 [Abstract] [Full Text] [Related]
9. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N. J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847 [Abstract] [Full Text] [Related]
10. Clinical Characteristics and Management of Cosecreting Thyroid Stimulating Hormone or Prolactin Pituitary Growth Hormone Adenomas: A Case-Control Study. Mo C, Chen H, Xu J, Guo Y, Wang Y, Li Z, Tong T, Gui S, Zhong L. Endocr Pract; 2024 May; 30(5):441-449. PubMed ID: 38307455 [Abstract] [Full Text] [Related]
11. Novel features of tumors that secrete both growth hormone and prolactin in acromegaly. Nyquist P, Laws ER, Elliott E. Neurosurgery; 1994 Aug; 35(2):179-83; discussion 183-4. PubMed ID: 7969823 [Abstract] [Full Text] [Related]
12. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center. Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T. Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132 [Abstract] [Full Text] [Related]
13. In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cells. Cuny T, Zeiller C, Bidlingmaier M, Défilles C, Roche C, Blanchard MP, Theodoropoulou M, Graillon T, Pertuit M, Figarella-Branger D, Enjalbert A, Brue T, Barlier A. Endocr Relat Cancer; 2016 Jul; 23(7):509-19. PubMed ID: 27267119 [Abstract] [Full Text] [Related]
14. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria. Hazer DB, Işık S, Berker D, Güler S, Gürlek A, Yücel T, Berker M. J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496 [Abstract] [Full Text] [Related]
15. Growth hormone isoforms in acromegalic patients before and after treatment with octreotide LAR. Lima GA, Wu Z, Silva CM, Barbosa FR, Dias JS, Schrank Y, Strasburger CJ, Gadelha MR. Growth Horm IGF Res; 2010 Apr; 20(2):87-92. PubMed ID: 19884028 [Abstract] [Full Text] [Related]
16. Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature. Almeida JP, Ruiz-Treviño AS, Liang B, Omay SB, Shetty SR, Chen YN, Anand VK, Grover K, Christos P, Schwartz TH. J Neurosurg; 2018 Aug; 129(2):404-416. PubMed ID: 28862548 [Abstract] [Full Text] [Related]